PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-59.30%
Negative 5Y CAGR while SMR.AX stands at 52.01%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-30.20%
Negative 3Y CAGR while SMR.AX stands at 328.33%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
94.58%
OCF/share CAGR of 94.58% while SMR.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-105.84%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
88.82%
3Y OCF/share CAGR under 50% of SMR.AX's 1814.65%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
121.88%
10Y net income/share CAGR of 121.88% while SMR.AX is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
377.12%
Positive 5Y CAGR while SMR.AX is negative. John Neff might view this as a strong mid-term relative advantage.
149.43%
Below 50% of SMR.AX's 388.69%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-87.09%
Negative equity/share CAGR over 10 years while SMR.AX stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
105.50%
Equity/share CAGR of 105.50% while SMR.AX is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
539.08%
Equity/share CAGR of 539.08% while SMR.AX is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.